CalciMedica expanded its board from 7 to 8 directors on July 2, 2026, appointing Dr. Evgeny Zaytsev as a Class I director. He will receive an annual cash retainer of $40,000 and an option for 20,000 shares vesting monthly over three years. Separately, director Fred Middleton informed the board of his retirement effective at the 2026 annual meeting, which will bring the board back to 7 members. Middleton’s departure is not due to any disagreement with the company.
Who are the top institutional investors holding CALCIMEDICA INC (CALC)?
Major stakeholders currently include Jane Street Group, LLC ($96.4K), Vanguard Capital Management LLC ($91.3K), Renaissance Technologies LLC ($69.2K). Based on the latest 13F filings, there are a total of 28 tracked investment funds and institutions maintaining positions in CALC.
What is the overall institutional sentiment toward CALC recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $23.5M, driven by 14 managers accumulating shares while 16 reduced their exposure.
Which institutions have been selling or reducing their CALC positions?
In the latest period, 5 funds trimmed their holdings, and 11 managers completely exited their positions. The aggregate reported sell value was $18.5M.
Are there any notable investors adding CALC to their portfolios?
Yes, buying activity remains notable. 10 institutions opened new positions in {ticker}, and 4 existing holders added to their shares. The total reported buy value for the quarter amounted to $426.8K.
Related Stocks
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter